A carregar...
Management of infusion reactions associated with cetuximab treatment: A case report
Cetuximab is a drug targeting the epidermal growth factor receptor, which is indicated for the treatment of unresectable advanced or recurrent head and neck or colorectal cancer. Cetuximab also enhances the cytotoxic effects of radiation in squamous cell carcinoma. The severity of infusion reactions...
Na minha lista:
| Publicado no: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451859/ https://ncbi.nlm.nih.gov/pubmed/28588776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1242 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|